Hematopoietic stem cell transplantation for the treatment of severe autoimmune diseases

  • Alan Tyndall
  • Jacob M. van Laar
Part of the Progress in Inflammation Research book series (PIR)


In humans, autoimmune diseases (ADs) represent a heterogeneous group of disorders with diverse genetic and environmental etiological factors.


Systemic Lupus Erythematosus Hematopoietic Stem Cell Transplantation Allogeneic Hematopoietic Stem Cell Transplantation Haematopoietic Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Marmont A, Gratwohl A, Vischer T (1995) Haematopoietic precursor cell transplants for autoimmune diseases. Lancet 345: 978CrossRefGoogle Scholar
  2. 2.
    Tamm M, Gratwohl A, Tichelli A, Perruchoud AP, Tyndall A (1996) Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease. Ann Rheum Dis 55(10): 779–780CrossRefPubMedGoogle Scholar
  3. 3.
    Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345(5): 340–350CrossRefPubMedGoogle Scholar
  4. 4.
    Medzhitov R, Janeway CA, Jr (2002) Decoding the patterns of self and non-self by the innate immune system. Science 296(5566): 298–300CrossRefPubMedGoogle Scholar
  5. 5.
    Tisch R, McDevitt H (1996) Insulin-dependent diabetes mellitus. Cell 85(3): 291–297CrossRefPubMedGoogle Scholar
  6. 6.
    Shevach EM (2002) CD4+ CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2(6): 389–400PubMedGoogle Scholar
  7. 7.
    Kamradt T, Mitchison NA (2001) Tolerance and autoimmunity. N Engl J Med 344(9): 655–664CrossRefPubMedGoogle Scholar
  8. 8.
    McKendry RJ, Huebsch L, Leclair B (1996) Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year follow up. Arthritis Rheum 39(7): 1246–1253CrossRefPubMedGoogle Scholar
  9. 9.
    Minchinton RM, Waters AH, Rendra J, Barrett AJ (1982) Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft. Lancet 2(8299): 627–629CrossRefPubMedGoogle Scholar
  10. 10.
    Sturfeit G, Lenhoff S, Sallerfors B, Nived O, Truedsson L, Sjoholm AG (1996) Transplantation with allogenic bone marrow from a donor with systemic lupus erythematosus (SLE): successful outcome in the recipient and induction of an SLE flare in the donor. Ann Rheum Dis 55(9): 638–641CrossRefGoogle Scholar
  11. 11.
    Denman AM, Russell AS, Denman EJ (1969) Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol 5(6): 567–595PubMedGoogle Scholar
  12. 12.
    Morton JI, Siegel BV (1974) Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice. Proc Natl Acad Sei USA 71(6): 2162–2165CrossRefGoogle Scholar
  13. 13.
    van Bekkum DW (2000) Stem cell transplantation in experimental models of autoimmune disease. J Clin Immunol 20(1): 10–16CrossRefPubMedGoogle Scholar
  14. 14.
    Ikehara S (2001) Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp Hematol 29(6): 661–669CrossRefPubMedGoogle Scholar
  15. 15.
    van Bekkum DW (2000) Conditioning regimens for the treatment of experimental arthritis with autologous bone marrow transplantation. Bone Marrow Transplant 25(4): 357–364CrossRefPubMedGoogle Scholar
  16. 16.
    Knaan-Shanzer S, Houben P, Kinwel-Bohre EP, van Bekkum DW (1991) Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation. Bone Marrow Transplant 8(5): 333–338PubMedGoogle Scholar
  17. 17.
    Tyndall A, Gratwohl A (1997) Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease. Curr Opin Hematol 4(6): 390–394CrossRefPubMedGoogle Scholar
  18. 18.
    McSweeney PA, Nash RA, Storb R, Furst DE, Gauthier J, Sullivan KM (1997) Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. J Rheumatol (Suppl) 48: 79–84Google Scholar
  19. 19.
    Gratwohl A, Passweg J, Gerber I, Tyndall A (2001) Stem cell transplantation for autoimmune diseases. Best Pract Res Clin Haematol 14(4): 755–776CrossRefPubMedGoogle Scholar
  20. 20.
    Binks M, Passweg JR, Furst D, McSweeney P, Sullivan K, Besenthal C et al (2001) Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: Procedure related mortality and impact on skin disease. Ann Rheum Dis 60(6): 577–584CrossRefPubMedGoogle Scholar
  21. 21.
    McSweeney PA, Nash RA, Sullivan KM, Storek J, Crofford LJ, Dansey R et al (2002) High-dose immunosuppressive therapy for severe systemic sclerosis: Initial outcomes. Blood 100(5): 1602–1610PubMedGoogle Scholar
  22. 22.
    Moore J, Milliken S, David, Biggs J, Brooks P (2001) Peripheral blood stem cell transplantation for rheumatoid arthritis-Australian experience. J Rheumatol (Suppl) 64: 8–12Google Scholar
  23. 23.
    Barron KS, Wallace C, Woolfrey CEA, Laxer RM, Hirsch R, Horwitz M et al (2001) Autologous stem cell transplantation for pediatric rheumatic diseases. J Rheumatol 28(10): 2337–2358PubMedGoogle Scholar
  24. 24.
    Traynor AE, Schroeder J, Rosa RM, Cheng D, Stefka J, Mujais S et al (2000) Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 356(9231): 701–707CrossRefPubMedGoogle Scholar
  25. 25.
    Bingham S, Veale D, Fearon U, Isaacs JD, Morgan G, Emery P et al (2002) High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: Short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum 46(3): 837–839CrossRefPubMedGoogle Scholar
  26. 26.
    Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L et al (2000) Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355(9218): 1875–1881CrossRefPubMedGoogle Scholar
  27. 27.
    Brodsky RA, Petri M, Smith BD, Seifter EJ, Spivak JL, Styler M et al (1998) Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med 129(12): 1031–1035PubMedGoogle Scholar
  28. 28.
    Baldwin JL, Storb R, Thomas ED, Mannik M (1977) Bone marrow transplantation in patients with gold-induced marrow aplasia. Arthritis Rheum 20(5): 1043–1048CrossRefPubMedGoogle Scholar
  29. 29.
    Jacobs P, Vincent MD, Martell RW (1986) Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia. Bone Marrow Transplant 1(2): 237–239PubMedGoogle Scholar
  30. 30.
    Lowenthal RM, Cohen ML, Atkinson K, Biggs JC (1993) Apparent cure of rheumatoid arthritis by bone marrow transplantation. J Rheumatol 20(1): 137–140PubMedGoogle Scholar
  31. 31.
    Eedy DJ, Burrows D, Bridges JM, Jones FG (1990) Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 300(6729): 908CrossRefPubMedGoogle Scholar
  32. 32.
    Yin JA, Jowitt SN (1992) Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 9(1): 31–33PubMedGoogle Scholar
  33. 33.
    Vento S, Cainelli F, Renzini C, Ghironzi G, Concia E (1996) Resolution of autoimmune hepatitis after bone-marrow transplantation. Lancet 348(9026): 544–545CrossRefPubMedGoogle Scholar
  34. 34.
    McAllister LD, Beatty PG, Rose J (1997) Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis. Bone Marrow Transplant 19(4): 395–397CrossRefPubMedGoogle Scholar
  35. 35.
    Nelson JL, Torrez R, Louie FM, Choe OS, Storb R, Sullivan KM (1997) Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. J Rheumatol (Suppl) 48: 23–29Google Scholar
  36. 36.
    Ferraccioli G, Damato R, De Vita S, Fanin R, Damiani D, Baccarani M (2001) Haematopoietic stem cell transplantation (HSCT) in a patient with Sjogren’s syndrome and lung malt lymphoma cured lymphoma not the autoimmune disease. Ann Rheum Dis 60(2): 174–176CrossRefPubMedGoogle Scholar
  37. 37.
    Salzman TJ, Jackson C (1994) Clinical remission of myasthenia gravis in a patient after high dose therapy and autologous stem cell transplantation with CD 34+ stem cells. Blood 94(Suppl): 206aGoogle Scholar
  38. 38.
    Euler HH, Marmont AM, Bacigalupo A, Fastenrath S, Dreger P, Hoffknecht M et al (1996) Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation. Blood 88(9): 3621–3625PubMedGoogle Scholar
  39. 39.
    Snowden JA, Patton WN, O’Donnell JL, Hannah EE, Hart DN (1997) Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin’s lymphoma. Bone Marrow Transplant 19(12): 1247–1250CrossRefPubMedGoogle Scholar
  40. 40.
    Meloni G, Capria S, Vignetti M, Mandelli F, Modena V (1997) Blast crisis of chronic myelo-genous leukemia in long-lasting systemic lupus erythematosus: Regression of both diseases after autologous bone marrow transplantation. Blood 89(12): 4659PubMedGoogle Scholar
  41. 41.
    Jondeau K, Job-Deslandre C, Bouscary D, Khanlou N, Menkes CJ, Dreyfus F (1997) Remission of nonerosive polyarthritis associated with Sjogren’s syndrome after autologous hematopoietic stem cell transplantation for lymphoma. J Rheumatol 24(12): 2466–2468PubMedGoogle Scholar
  42. 42.
    Cooley HM, Snowden JA, Grigg AP, Wicks IP (1997) Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy. Arthritis Rheum 40(9):1712–1715CrossRefPubMedGoogle Scholar
  43. 43.
    Kashyap A, Forman SJ (1998) Autologous bone marrow transplantation for non-Hodgkin’s lymphoma resulting in long-term remission of coincidental Crohn’s disease. Br J Haematol 103(3): 651–652CrossRefPubMedGoogle Scholar
  44. 44.
    Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R (2000) Crohn’s disease complicated by relapsed extranodal Hodgkin’s lymphoma: Prolonged complete remission after unmanipulated PBPC autotransplant. Bone Marrow Transplant 26(8): 921–923CrossRefPubMedGoogle Scholar
  45. 45.
    Durez P, Toungouz M, Schandene L, Lambermont M, Goldman M (1998) Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis. Lancet 352: 881CrossRefPubMedGoogle Scholar
  46. 46.
    McColl G, Kohsaka H, Szer J, Wicks I (1999) High-dose chemotherapy and syngeneic hemopoietic stem-cell transplantation for severe, seronegative rheumatoid arthritis. Ann Intern Med 131: 507–509PubMedGoogle Scholar
  47. 47.
    Pavletic SZ, O’Dell JR, Pirruccello SJ, Ursick MM, Haire CE, Sharp JG, Kessinger A, Klassen LW (2001) Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: The University of Nebraska experience. J Rheumatol (Suppl) 64: 13–20Google Scholar
  48. 48.
    Bingham SJ, Snowden J, McGonagle D, Richards S, Isaacs J, Morgan G, Emery P (2001) Autologous stem cell transplantation for rheumatoid arthritis-interim report of 6 patients. J Rheumatol (Suppl) 64: 21–24Google Scholar
  49. 49.
    Verburg RJ, Kruize AA, van den Hoogen FH, Fibbe WE, Petersen EJ, Preijers F et al (2001) High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy. Arthritis Rheum 44: 754–760CrossRefPubMedGoogle Scholar
  50. 50.
    Kim KC, Lee IH, Choi JH, Oh MR, Ahn MJ, Kim SY (2002) Autologous stem cell transplantation in the treatment of refractory rheumatoid arthritis. J Korean Med Sei 17: 129–132Google Scholar
  51. 51.
    Moore J, Brooks P, Milliken S, Biggs J, Ma D, Handel M et al (2002) A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum 46: 2301–2309CrossRefPubMedGoogle Scholar
  52. 52.
    Lanza F, Dominici M, Govoni M, Moretti S, Campioni D, Corte RL et al (2000) Prolonged remission state of refractory adult onset Still’s disease following CD34-selected autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 25: 1307–1310CrossRefPubMedGoogle Scholar
  53. 53.
    Wulffraat N, van Royen A, Bierings M, Vossen J, Kuis W (1999) Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis. Lancet 353: 550–553CrossRefPubMedGoogle Scholar
  54. 54.
    Quartier P, Prieur AM, Fischer A (1999) Haemopoietic stem-cell transplantation for juvenile chronic arthritis. Lancet 353: 1885–1886CrossRefPubMedGoogle Scholar
  55. 55.
    Nakagawa R, Kawano Y, Yoshimura E, Suzuya H, Watanabe T, Kanamaru S et al (2001) Intense immunosuppression followed by purified blood CD34+ cell autografting in a patient with refractory juvenile rheumatoid arthritis. Bone Marrow Transplant 27: 333–336CrossRefPubMedGoogle Scholar
  56. 56.
    Tyndall A, Black C, Finke J, Winkler J, Mertlesmann R, Peter HH, Gratwohl A (1997) Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet 349: 254CrossRefPubMedGoogle Scholar
  57. 57.
    Martini A, Maccario R, Ravelli A, Montagna D, De Benedetti F, Bonetti F, Viola S, Zecca M, Perotti C, Locatelli F (1999) Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis. Rheumatology 38: 773CrossRefPubMedGoogle Scholar
  58. 58.
    Farge D, Marolleau JP, Zohar S, Marjanovic Z, Cabane J, Mounier N et al (2002) Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I–II study. Br J Haematol 119: 726–739CrossRefPubMedGoogle Scholar
  59. 59.
    Marmont AM, van Lint MT, Gualandi F, Bacigalupo A (1997) Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration. Lupus 6: 545–548CrossRefPubMedGoogle Scholar
  60. 60.
    Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R, Mariani G (1998) Autologous peripheral blood stem and progenitor (CD34+) cell transplantation for systemic lupus erythematosus complicated by Evans syndrome. Lupus 7: 492–494CrossRefPubMedGoogle Scholar
  61. 61.
    Fouillard L, Gorin NC, Laporte JP, Leon A, Brantus JF, Miossec P (1999) Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood. Lupus 8: 320–323CrossRefPubMedGoogle Scholar
  62. 62.
    Trysberg E, Lindgren I, Tarkowski A (2000) Autologous stem cell transplantation in a case of treatment resistant central nervous system lupus. Ann Rheum Dis 59: 236–238CrossRefPubMedGoogle Scholar
  63. 63.
    Shaughnessy PJ, Ririe DW, Ornstein DL, Kissack B, Bickford DJ, Molina R et al (2001) Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue. Bone Marrow Transplant 27: 221–224CrossRefPubMedGoogle Scholar
  64. 64.
    Rosen O, Hiepe F, Massenkeil G, Thiel A, Arnold R (2001) Relapse of systemic lupus erythematosus. Lancet 357: 807–808CrossRefPubMedGoogle Scholar
  65. 65.
    Wulffraat NM, Sanders EA, Kamphuis SS, Rijkers GT, Kuis W, Lilien M, Slaper-Cortenbach IC (2001) Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus. Arthritis Rheum 44: 728–731CrossRefPubMedGoogle Scholar
  66. 66.
    Brunner M, Greinix HT, Redlich K, Knobl P, Smolen J, Leitner G et al (2002) Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: a case report. Arthritis Rheum 46: 1580–1584CrossRefPubMedGoogle Scholar
  67. 67.
    Traynor AE, Barr WG, Rosa RM, Rodriguez J, Oyama Y, Baker S et al (2002) Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rheum 46: 2917–2923CrossRefPubMedGoogle Scholar
  68. 68.
    Myllykangas-Luosujarvi R, Jantunen E, Kaipiainen-Seppanen O, Mahlamaki E, Nousiainen T (2000) Autologous peripheral blood stem cell transplantation in a patient with severe mixed connective tissue disease. Scand J Rheumatol 29(5): 326–327CrossRefPubMedGoogle Scholar
  69. 69.
    Baron F, Ribbens C, Kaye O, Fillet G, Malaise M, Béguin Y (2000) Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. Br J Haematol 110(2): 339–342CrossRefPubMedGoogle Scholar
  70. 70.
    Bingham S, Griffiths B, Mc Gonagle D, Snowden JA, Morgan G, Emery P (2001) Autologous stem cell transplantation for rapidly progressive jo-1-positive polymyositis with long-term follow-up. Br J Haematol 113: 840–841CrossRefPubMedGoogle Scholar
  71. 71.
    Burt RK, Traynor AE, Cohen B, Karlin KH, Davis FA, Stefoski D et al (1998) T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant 21: 537–541CrossRefPubMedGoogle Scholar
  72. 72.
    Fassas A, Anagnostopoulos A, Kazis A, Kapinas K, Sakellari I, Kimiskidis V et al (2000) Autologous stem cell transplantation in progressive multiple sclerosis — an interim analysis of efficacy. J Clin Immunol 20: 24–30CrossRefPubMedGoogle Scholar
  73. 73.
    Openshaw H, Lund BT, Kashyap A, Atkinson R, Sniecinski I, Weiner LP, Forman S (2000) Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring. Biol Blood Marrow Transpl 6: 563–575CrossRefGoogle Scholar
  74. 74.
    Kozak T, Havrdova E, Pit’ha J, Gregora E, Pytlik R, Maaloufova J et al (2000) High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 25: 525–531CrossRefPubMedGoogle Scholar
  75. 75.
    Burt RK, Traynor AE, Oyama Y, Craig R (2003) High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood 101: 2064–2066CrossRefPubMedGoogle Scholar
  76. 76.
    Rosen O, Thiel A, Massenkeil G, Hiepe F, Haupl T, Radtke H et al (2000) Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoabla tion and ex vivo depletion of mononuclear cells. Arthritis Res 2: 327–336CrossRefPubMedGoogle Scholar
  77. 77.
    Rabusin M, Andolina M, Maximova N, Lepore L, Parco S, Tuveri G, Jankovic G (2000) Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease. Haematologica 85 (Suppl): 81–85PubMedGoogle Scholar
  78. 78.
    Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R (2001) Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease. Am J Hematol 66: 75–79CrossRefPubMedGoogle Scholar
  79. 79.
    Snowden J, Passweg J, Moore JJ et al (2004) Antologous hemapoietic stem cell transplantation in severe rheumatoid arthritis; a report from the EBMT and ABMTR. J Rheumatol 31: 482–488PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2005

Authors and Affiliations

  • Alan Tyndall
    • 1
  • Jacob M. van Laar
    • 2
  1. 1.Department of RheumatologyUniversity of BasleBaselSwitzerland
  2. 2.Department of RheumatologyLeiden University Medical CenterLeidenThe Netherlands

Personalised recommendations